Immunovia AB (publ) (IMMNOV.ST)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
- BRIEF-Immunovia Aims To Reach SEK 250-300 Million In Turnover In 2021
- BRIEF-Immunovia AB Q4 Net Sales Sek 26,000 Versus Sek 106,000 Year Ago
- BRIEF-Immunovia: Massachusetts General Hospital Joins PanFAM-1 Prospective Study
- BRIEF-Immunovia Signs LoI With DD2 Center
- BRIEF-Immunovia Collaborates With University Of Pittsburgh